#ACR22 social media talk, very meta Part 1️⃣: optimize your conference tweeting
If you're reading this you probably know all of this!

The first pro-tip was figure out the conference hashtag
The second? Engage with others in rheum
#ACR22

#ACR22 infection (COVID) posters Abs 0784 @CCalabreseDO

Cleveland Clinic breakthrough infections, including data on n=21 who received Evusheld

📌Publication here: pubmed.ncbi.nlm.nih.gov/35791921/

#ACR22

#ACR22 #Feedback

https://twitter.com/tuhina_neogi/status/1591801430641618946

The EULAR e posters were tiny (bad) but speakers could zoom in and out (good)

That would have been nice for #IgniteTalks #ACR22

#ACR22 epidemiology posters Abs 0700 @zach_wallace_md
💻Using NLP, ML algorithms to identify ANCA vasculitis cases

They also looked at the difference in performance metrics with/without filtering keywords

An explosion of NLP studies in rheum! #ACR22

We have learned quite quickly that a virtual ONLY poster hall mixed into a hybrid meeting doesn't work well.

Poor wifi and the crashing platform compound the problem

And if it's online ONLY, is that truly hybrid?

#ACR22

https://twitter.com/k_lauper/status/1591425990844190720

This is not a complaint thread. I am hoping we can have discussion about what works/doesn't work, and what could be done next year for #ACR23

Biostatician @MikeLaValley8 @BU_BMC_Rheum presents a quick overview on how to appropriately interpret results from studies #ACR22

Of course this is not an exhaustive deep dive, but covers some common errors of interpretation @MikeLaValley8 @BU_BMC_Rheum First, what is your research question? What is the question you are trying to answer with t he study?

👉Does this exposure CAUSE this outcome?

#ACR22

Really enthused that some of the @rheum_covid #ILAR grant recipients could join us at this event tonight & talk about their work and their experiences
@panlarleague @aflarrheum

#ACR22 @rheum_covid @PanlarLeague @AFLARRheum Carolina Isnardi - Argentina
on behalf of the SAR-COVID registry

@gponsestel

#ACR22

It’s real! The @rheum_covid event where we all finally meet off zoom #ACR22 .@philipcrobinson as the @rheum_covid chair of the steering committee thanking everyone for their contributions #ACR22

At the GRA gathering, @jyazdanymd gives an overview of what @rheum_covid has accomplished since March 2020

The theme is the power of global collaboration

#ACR22 @JYazdanyMD @rheum_covid We've seen this slide many times but this is the final tally: >30k cases reported to @rheum_covid including the @eular registry

#ACR22

#ACR22 spondyloarthritis treatment oral abstract session 🌟Abs 0542 @sofiaramiro82
@official_asas @eular_org revised recommendations for axSpA management

https://twitter.com/Official_ASAS/status/1549711465879412736?s=20&t=dJDrNfaOueitQz6L1IdoDA

#ACR22

More work from the @bu_bmc_rheum group & collaborators in #OA using data from #MOST

#ACR22 @BU_BMC_Rheum Abs 1912 @profdeepakkumar

❓Is altered facilitatory and inhibitory nociceptive functioning is related to lower physical activity in people with knee OA?

#ACR22

Brooke McGinley (mentor @mikelavalley8) with @bu_bmc_rheum @tuhina_neogi

Identifying subgroups of pts undergoing knee replacement in #MOST

#ACR22 @MikeLaValley8 @BU_BMC_Rheum @Tuhina_Neogi 🔹In the US more than 640,000 knee replacements annually

🔹In the US estimated 10.2 billion in annual costs

🔹Knee osteoarthritis consists of different phenotypes often leading to a knee replacement outcome

#ACR22

In the ortho/rehab oral session, which is really an #OA session we have former @bu_bmc_rheum postdoc @kosakuaoyagi now with his own lab at @utep

Presenting his work with @tuhina_neogi: trajectories of pain sensitization in knee OA

#ACR22 @BU_BMC_Rheum @KosakuAoyagi @UTEP @Tuhina_Neogi What is central pain sensitization?
Altered CNS nociceptive signaling

👉It's present in ~30% of people with knee OA & contributes to the pain experience in OA

#ACR22

.@DPatWCorrigan with #MOST data @kecostello @ProfCaraLewis @MikeLaValley8 @tuhina_neogi @patellaprof @BU_BMC_Rheum

oral in the LBP/ortho/rehab session

#ACR22 @DPatWCorrigan @kecostello @ProfCaraLewis @MikeLaValley8 @Tuhina_Neogi @patellaprof @BU_BMC_Rheum Individuals with unilateral symptomatic knee OA commonly walk in a way that unloads their knee with OA

This unloading can relieve pain, but may shift the load in such a way to increase risk of OA in the contralateral knee

#ACR22

Ideally “fun-fierce” #ACR22 #ACRKnowledgeBowl

sadly NOT live streaming About to start! I bet @joannamarco likes the 🐻 team from UCLA #ACR22 #ACRKnowledgeBowl

Happy bday to the peds rheum half of the team!

Highlighting again some #ICYMI excellent #gout #CPPD content from #GCAN2022

#ACR22 The #gout mega GWAS will be presented by @TonyMerriman2 *on behalf of a very large team* at the third plenary session

https://twitter.com/rheum_cat/status/1583885607209553920?s=20&t=itZMZw_JQcXtOohBt93JnQ

#ACR22

#ACR22 Spondyloarthritis posters Abs 0382 McDermott, et al.

MGB study of new axSpA cohort (n=555) investigating dx delay

📌Dx delay in axSpA is well described:

https://twitter.com/rheum_cat/status/1318235472489971712?s=20&t=gZHYWeHT9uIHL5wR4ZbesA

#ACR22

Dr Carol Langford for the clinical #YearInReview #ACR22 1⃣GLORIA pragmatic trial in RA >= 65 yrs, of add on low dose prednisolone

pubmed.ncbi.nlm.nih.gov/35641125/

NNH 9.5

#ACR22

Here is the keynote speaker @cuttingforstone for #ACR22 @cuttingforstone A sobering start as he shows us some @FacesOfCOVID - those in the medical field who died during the pandemic

#ACR22

#ACR22 Posters: Disparities
Abs 0095 Desilet, et al.

Work in VARA

🔎Research Q: Does rural vs urban residence impact new bDMARD start in RA?
We know from other studies of the disparities in outcomes associated with rural residence (vs urban). Abs 0094, cont'd #ACR22

Among those with persistently active RA (by DAS28), n=1461
there was no sig association between rural (vs urban) residence and new bDMARD start

But, study also found <50% with new bDMARD Rx despite persistent dz activity - thus many not getting T2T

#ACR22 #IgniteTalks 6C
Will be presented live Sun Nov 13 at 2pm 🌟Abs 1785 Bartlett, et al.
❓Research Q: Among individuals with RA with depression, where there distinct groups with clear trajectories in terms of their PROs?

#ACR22